Study of Proteins in Tumor Samples From Patients With Non-Small Cell Lung Cancer
Withdrawn before enrolling
Conditions studied: Lung Cancer
In brief
This research studies protein in tumor samples from patients with non-small cell lung cancer. Finding specific proteins in tumor tissue samples from patients with cancer may help doctors tell what type of lung cancer a patient has and plan better treatment.
Key facts
- Study ID
- NCT01415739
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 0
- Starts
- 2011-10-01
- Expected to finish
- 2015-08-01
- Last updated by the study team
- 2019-01-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients must have been registered on CALGB-9761
- Stage I disease
- Treatment-naive patients
- A representative paraffin block of the primary tumor must be available from patients on CALGB-9761 and submitted to the CALGB Pathology Coordinating Office
- A separate consent form is not required for this study, as permission for research to be performed on the tissue blocks is included in the consent form for CALGB 9761
- Institutional review board (IRB) review and approval at the institution where the laboratory work will be performed is required
Where it is running
- Alliance for Clinical Trials in Oncology — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.